The ACADVL gene provides instructions for an enzyme that helps break down certain long-chain fats so your cells can make energy. This gene helps your body keep the heart, liver, and muscles fueled during fasting, illness, or exercise. If the ACADVL gene does not work properly, it can cause VLCAD deficiency, which may lead to low blood sugar, low energy, muscle pain or muscle breakdown, and sometimes heart problems. Symptoms and severity can vary a lot from one person to another.
What is a gene?
Genes are stretches of DNA that hold information cells use to make molecules or regulate processes in the body. Some genes provide instructions for producing proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ACADVLGene function
What if the gene works
The ACADVL gene helps cells break down very long chain fats for energy, especially during fasting or exercise. This supports organs with high energy needs, including the heart, liver, and muscles.
Risk
What if the gene does not work
Variants in the ACADVL gene can cause VLCAD deficiency, so the body struggles to use some fats for energy. More severe variants often cause low blood sugar or heart problems, while milder variants may cause later muscle pain or breakdown.
Treatment
What does that mean for your treatment
Pathogenic variants in the ACADVL gene guide management with avoidance of fasting, a low long chain fat diet, and rapid carbohydrate or glucose support during illness, surgery, or heavy exercise. Some people may also benefit from medium chain triglycerides or triheptanoin, chosen according to age, symptoms, and energy needs.
Conditions associated with ACADVL
Gene function
What if the gene works
Your body uses the ACADVL gene to help turn certain fats into energy. Understanding ACADVL gene function helps explain how your cells tap into stored fat between meals and during longer activity. Inside mitochondria (the parts of cells that make energy), this gene supports an early step in breaking down long-chain fatty acids.
Inside mitochondria (the parts of cells that make energy), the ACADVL gene helps start the breakdown of long-chain fatty acids. Its protein performs one of the first steps needed to turn these fats into usable fuel.
When your body relies less on sugar, the ACADVL gene supports the use of stored fat for energy. This helps cells keep making fuel in a steady way between meals and during longer periods of activity.
The ACADVL gene is tailored for long-chain fatty acids, which are larger fat molecules your cells cannot use in one simple step. This gives the body a way to access energy from a wider range of dietary and stored fats.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ACADVL gene can make its enzyme unstable, poorly folded, or nearly absent, reducing the cell's ability to process very long chain fats. This is how ACADVL gene variants affect enzyme activity, from milder changes that leave some activity to more severe variants that remove it almost completely. Lower remaining activity is often linked to earlier and broader VLCAD deficiency features, while partial activity may lead to a later, milder pattern.
How variants are linked to conditions
Pathogenic variants in the ACADVL gene cause very long chain acyl CoA dehydrogenase deficiency, often called VLCAD deficiency. This well established ACADVL gene and VLCAD deficiency link can show up in different ways, from feeding difficulties, low blood sugar, or heart involvement in infancy to muscle pain, weakness, or dark urine after exercise in older children and adults. The pattern can vary widely, even within the same family.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ACADVL, the main risk comes from inheriting harmful changes in both copies of the gene. In people living with ACADVL-related VLCAD deficiency, long periods without food, illness, hard exercise, and sometimes cold exposure can raise the chance of low blood sugar, muscle pain, or heart-related problems. Early diagnosis and avoiding these triggers can help lower the risk of serious episodes.
Inheritance of ACADVL variants
Variants in the ACADVL gene are inherited in an autosomal recessive pattern. In families asking how ACADVL gene variants are inherited, this usually means a child needs to inherit one altered copy from each parent to have ACADVL related very long chain acyl CoA dehydrogenase deficiency. When both parents are carriers, each pregnancy has a 25% chance of the child having the condition, a 50% chance of the child being a carrier, and a 25% chance of the child inheriting two working copies. Boys and girls are affected equally.
What does my ACADVL result mean for my family?
For families with an ACADVL-related condition, close relatives may also carry the same gene change. Brothers and sisters may have the condition or be carriers even if they feel well, and other relatives may also be carriers. Because this condition is usually passed down in a recessive pattern, family testing discussions often focus on siblings, parents, and relatives planning children.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the ACADVL gene, doctors use genetic testing for ACADVL variants on a blood, saliva, or cheek swab sample. A lab reads the gene’s DNA code and compares it with the usual sequence to identify changes that may help explain symptoms or confirm a diagnosis.
When should I consider getting a genetic test?
Consider ACADVL testing if newborn screening suggests a problem breaking down certain fats, or if someone has repeated low blood sugar during fasting, heart muscle weakness, severe muscle pain, or dark urine after exercise or illness. It can also help when a close family member has a confirmed ACADVL change linked to this condition.
A genetic result is only one part of your health story
A genetic result can give useful insight, yet how much it can tell you varies with the condition and the kind of variant involved. Over time, the way the body works is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside the rest of a person’s care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better for one person, have less effect in another, or cause more side effects. This kind of difference is common and is one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies the relationship between genes and drugs to understand more clearly why the same treatment may work differently from one person to another. For many medicines, genes help influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are both more informed and more individualized. To explore this topic further, more information is available in the LearnHub.
Drugs influenced by the ACADVL gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medication response. If you have questions about side effects, new symptoms, or how your medicines fit with your overall health, talk with your doctor or pharmacist.
History
ACADVL entered medical genetics in the early 1990s, when researchers recognized that some children and adults with episodes of low blood sugar, muscle pain, or heart problems had a distinct inherited condition later linked to this gene. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped separate VLCAD deficiency from other fatty acid oxidation conditions. From these first observations, research expanded steadily. As DNA testing improved, ACADVL variants could be identified more directly, which made diagnosis clearer for affected families. Newborn screening programs later brought broader attention to ACADVL, because some babies could be identified soon after birth rather than only after becoming unwell. Over time, this shifted ACADVL from a rarely recognized finding to a more routinely detected inherited condition.